Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients

In December 2019, following a cluster of pneumonia cases in China caused by a novel coronavirus (CoV), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infection disseminated worldwide and, on March 11th, 2020, the World Health Organization officially declared the pandemic of...

Descripción completa

Detalles Bibliográficos
Autores principales: Colafrancesco, Serena, Scrivo, Rossana, Barbati, Cristiana, Conti, Fabrizio, Priori, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324709/
https://www.ncbi.nlm.nih.gov/pubmed/32655577
http://dx.doi.org/10.3389/fimmu.2020.01439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324709/
https://www.ncbi.nlm.nih.gov/pubmed/32655577
http://dx.doi.org/10.3389/fimmu.2020.01439

Ejemplares similares